
The author discusses how value-based payment models in chronic kidney disease can improve total cost and quality of care for patienst with chronic kidney disease (CKD).
Across the commercialization continuum, Precision Value & Health teams are focused on transforming data for heath and leveraging evidence and insights to tailor communications for every stakeholder. From payers to health systems, scientists to healthcare providers, and consumers to advocates, our results are designed to shift the trajectory and accelerate your success.
Precision Value & Health’s teams include: PRECISIONadvisors (global pricing and market access strategy), PRECISIONeffect (branding and launch experts), PRECISIONheor (evidence generation and strategy), PRECISIONscientia (medical communications), PRECISIONvalue (managed markets marketing), PRECISIONxtract (data-driven solutions and engagement).
The author discusses how value-based payment models in chronic kidney disease can improve total cost and quality of care for patienst with chronic kidney disease (CKD).
This article was written by Maureen Hennessey, PhD, CPCC, CPHQ, senior vice president and director of Value Transformation for PRECISIONvalue.
Published: September 25th 2020 | Updated:
Published: December 26th 2020 | Updated:
Published: June 12th 2020 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.